Varón de 70 años con trastorno sensitivomotor de instauración aguda en extremidades izquierdas

  1. Rodríguez, C. Alcahut
  2. Ramos-Araque, M.E.
  3. Martín, T. Segura
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2019

Serie: 12

Número: 70

Páginas: 4143-4144

Tipo: Artículo

DOI: HTTPS://DOI.ORG/10.1016/J.MED.2019.01.009 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Referencias bibliográficas

  • Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet. 2000;355(9211):1205-10.
  • Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093-104.
  • Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2014;45(7):2160-236.
  • Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016; 18(11):1609-78.
  • Paciaroni M, Agnelli G, Facocci N, Caso V, Becattini C, Marcheselli S. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: The RAF Study. Stroke. 2015;46(8):2175-82.
  • Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91.
  • Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2018;49(3):e46-e110.
  • Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015(3):CD000024.
  • Seiffge DJ, Traenka C, Polymeris A, Hert L, Peters N, Lyrer P. Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events. Neurology. 2016;87(18):1856-62.
  • You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence based clinical practice guidelines. Chest. 2012;141(2)Suppl: e531S-e75S.
Fuente de los datos: Dialnet